Literature DB >> 3489122

Impaired cellular immune responses in chronic renal failure: evidence for a T cell defect.

P Kurz, H Köhler, S Meuer, T Hütteroth, K H Meyer zum Büschenfelde.   

Abstract

Cellular immune responses in vitro were studied in 24 patients on chronic hemodialysis and 16 healthy volunteers with normal kidney function. Patients on maintenance hemodialysis had lymphopenia with diminished numbers of both T4+ and T8+ T-lymphocytes. The T4/T8 ratios were within the normal range. Peripheral blood lymphocytes (PBL) showed a diminished proliferative response upon stimulation with concanavalin A, phytohemagglutinin and pokeweed mitogen. When cell surface antigens were used for stimulation (mixed lymphocyte culture) uremic lymphocytes also showed a lower proliferation rate. Although without statistical conformation, there was a tendency by uremic PBL to produce less IL-2 as compared to healthy controls. Moreover, in a PWM driven system, peripheral blood lymphocytes from uremics produced significantly less IgG than PBL from normals. These results support the notion that a profound defect in lymphocyte function accounts at least, in part, for the observed immunodeficiency of uremic patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3489122     DOI: 10.1038/ki.1986.129

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  40 in total

1.  Response to HBV vaccination in patients with severe liver disease. Absence of an HLA effect.

Authors:  D H Van Thiel; J S Gavaler
Journal:  Dig Dis Sci       Date:  1992-09       Impact factor: 3.199

2.  Sex bias in response to hepatitis B vaccination in end-stage renal disease patients: Meta-analysis.

Authors:  Hossein Khedmat; Aghdas Aghaei; Mohammad Ebrahim Ghamar-Chehreh; Shahram Agah
Journal:  World J Nephrol       Date:  2016-01-06

3.  Pulmonary mucormycosis presenting as massive fatal hemoptysis in a hemodialytic patient with chronic renal failure.

Authors:  S Yagihashi; K Watanabe; K Nagai; M Okudaira
Journal:  Klin Wochenschr       Date:  1991-03-18

4.  Immune status of children on continuous ambulatory peritoneal dialysis.

Authors:  S Hisano; C Miyazaki; K Hatae; Y Kaku; I Yamane; K Ueda; S Okamua
Journal:  Pediatr Nephrol       Date:  1992-03       Impact factor: 3.714

5.  Deoxyribonuclease activity in lymphocytes of patients with chronic renal failure treated conservatively.

Authors:  R Adamiec; Z Szewczyk; J Prochera; J Szopa
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

6.  Fatal fungal peritonitis in an adolescent on continuous ambulatory peritoneal dialysis: association with deferoxamine.

Authors:  M Nakamura; W B Weil; D B Kaufman
Journal:  Pediatr Nephrol       Date:  1989-01       Impact factor: 3.714

7.  The immune status of uraemic children/adolescents with chronic renal failure and renal replacement therapy.

Authors:  R Drachman; M Schlesinger; H Shapira; A Drukker
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

8.  Children with chronic renal failure have reduced numbers of memory B cells.

Authors:  A H M Bouts; J C Davin; R T Krediet; L A H Monnens; J Nauta; C H Schröder; R A W van Lier; T A Out
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

9.  Inflammation, T-cell phenotype, and inflammatory cytokines in chronic kidney disease patients under hemodialysis and its relationship to resistance to recombinant human erythropoietin therapy.

Authors:  Elísio Costa; Margarida Lima; João Moura Alves; Susana Rocha; Petronila Rocha-Pereira; Elisabeth Castro; Vasco Miranda; Sameiro Faria Maria do; Alfredo Loureiro; Alexandre Quintanilha; Luís Belo; Alice Santos-Silva
Journal:  J Clin Immunol       Date:  2008-05       Impact factor: 8.317

10.  Toll-like receptors TLR4 (Asp299Gly and Thr399Ile) and TLR2 (Arg677Trp and Arg753Gln) gene polymorphisms in end-stage renal disease patients on peritoneal dialysis.

Authors:  Kamini Singh; Kashi Nath Prasad; Priyanka Mishra; Jahanarah Khatoon; Narayan Prasad; Amit Gupta; Janmejai Kumar Srivastava
Journal:  Int Urol Nephrol       Date:  2015-10-22       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.